{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:58:45Z","timestamp":1790290725995,"version":"4.1.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Natural Science Foundation of Changsha","award":["kq2208368"],"award-info":[{"award-number":["kq2208368"]}]},{"name":"the Natural Science Foundation of Hunan Province of China","award":["2023JJ30930"],"award-info":[{"award-number":["2023JJ30930"]}]},{"name":"the national key clinical specialist construction programs of China","award":["z047-02"],"award-info":[{"award-number":["z047-02"]}]},{"name":"the National Natural Science Foundation of China","award":["82470078"],"award-info":[{"award-number":["82470078"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Major Research Project for High-Level Talents of Healthcare in Hunan Province","award":["R2023032"],"award-info":[{"award-number":["R2023032"]}]},{"name":"the China Postdoctoral Science Foundation","award":["2025M772426"],"award-info":[{"award-number":["2025M772426"]}],"id":[{"id":"https:\/\/ror.org\/0426zh255","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"DOI":"10.1007\/s11095-026-04192-3","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:25:30Z","timestamp":1790281530000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Computational Design of a Trivalent Multi-Epitope mRNA Vaccine Candidate Against Western, Eastern, and Venezuelan Equine Encephalitis Viruses"],"prefix":"10.1007","author":[{"given":"Rongliu","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyou","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqun","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5883-0531","authenticated-orcid":false,"given":"Pinhua","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"issue":"12","key":"4192_CR1","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1080\/14787210.2022.2141224","volume":"20","author":"K Kehn-Hall","year":"2022","unstructured":"Kehn-Hall K, Bradfute SB. Understanding host responses to equine encephalitis virus infection: implications for therapeutic development. Expert Rev Anti Infect Ther. 2022;20(12):1551\u201366.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"4192_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00959","volume":"7","author":"SE Ronca","year":"2016","unstructured":"Ronca SE, Dineley KT, Paessler S. Neurological sequelae resulting from encephalitic alphavirus infection. Front Microbiol. 2016;7:959.","journal-title":"Front Microbiol"},{"issue":"3-4","key":"4192_CR3","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.vetmic.2009.08.023","volume":"140","author":"MA Zacks","year":"2010","unstructured":"Zacks MA, Paessler S. Encephalitic alphaviruses. Vet Microbiol. 2010;140(3\u20134):281\u20136.","journal-title":"Vet Microbiol"},{"issue":"2","key":"4192_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens14020193","volume":"14","author":"CM Woodson","year":"2025","unstructured":"Woodson CM, Carney SK, Kehn-Hall K. Neuropathogenesis of encephalitic alphaviruses in non-human primate and mouse models of infection. Pathogens. 2025;14(2):193.","journal-title":"Pathogens"},{"issue":"6","key":"4192_CR5","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1099\/jgv.0.001072","volume":"99","author":"R Chen","year":"2018","unstructured":"Chen R, Mukhopadhyay S, Merits A, Bolling B, Nasar F, Coffey LL, et al. ICTV Virus Taxonomy Profile: Togaviridae. J Gen Virol. 2018;99(6):761\u20132.","journal-title":"J Gen Virol"},{"issue":"10","key":"4192_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008876","volume":"16","author":"AC Holmes","year":"2020","unstructured":"Holmes AC, Basore K, Fremont DH, Diamond MS. A molecular understanding of alphavirus entry. PLoS Pathog. 2020;16(10):e1008876.","journal-title":"PLoS Pathog"},{"key":"4192_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8020273","author":"ZR Stromberg","year":"2020","unstructured":"Stromberg ZR, Fischer W, Bradfute SB, Kubicek-Sutherland JZ, Hraber P. Vaccine advances against Venezuelan, Eastern, and Western Equine Encephalitis Viruses. Vaccines (Basel). 2020. https:\/\/doi.org\/10.3390\/vaccines8020273.","journal-title":"Vaccines (Basel)"},{"issue":"8","key":"4192_CR8","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/S1473-3099(22)00052-4","volume":"22","author":"EE Coates","year":"2022","unstructured":"Coates EE, Edupuganti S, Chen GL, Happe M, Strom L, Widge A, et al. Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trial. Lancet Infect Dis. 2022;22(8):1210\u201320.","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"4192_CR9","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1016\/j.vaccine.2024.03.011","volume":"42","author":"C Fierro","year":"2024","unstructured":"Fierro C, Weidenthaler H, Vidojkovic S, Schmidt D, Gafoor Z, Stroukova D, et al. Safety and immunogenicity of a novel trivalent recombinant MVA-based equine encephalitis virus vaccine: a phase 1 clinical trial. Vaccine. 2024;42(10):2695\u2013706.","journal-title":"Vaccine"},{"issue":"31","key":"4192_CR10","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1016\/j.vaccine.2016.04.077","volume":"34","author":"D Hannaman","year":"2016","unstructured":"Hannaman D, Dupuy LC, Ellefsen B, Schmaljohn CS. A phase 1 clinical trial of a DNA vaccine for Venezuelan equine encephalitis delivered by intramuscular or intradermal electroporation. Vaccine. 2016;34(31):3607\u201312.","journal-title":"Vaccine"},{"issue":"4","key":"4192_CR11","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.ymthe.2018.12.013","volume":"27","author":"MM Samsa","year":"2019","unstructured":"Samsa MM, Dupuy LC, Beard CW, Six CM, Schmaljohn CS, Mason PW, et al. Self-amplifying RNA vaccines for Venezuelan equine encephalitis virus induce robust protective immunogenicity in mice. Mol Ther. 2019;27(4):850\u201365.","journal-title":"Mol Ther"},{"issue":"4","key":"4192_CR12","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","volume":"17","author":"N Pardi","year":"2018","unstructured":"Pardi N, Hogan MJ, Porter FW, Weissman D. mRNA vaccines - a new era in vaccinology. Nat Rev Drug Discov. 2018;17(4):261\u201379.","journal-title":"Nat Rev Drug Discov"},{"key":"4192_CR13","doi-asserted-by":"crossref","unstructured":"Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603\u201315.","DOI":"10.1056\/NEJMoa2034577"},{"issue":"7868","key":"4192_CR14","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s41586-021-03653-6","volume":"595","author":"U Sahin","year":"2021","unstructured":"Sahin U, Muik A, Vogler I, Derhovanessian E, Kranz LM, Vormehr M, et al. BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans. Nature. 2021;595(7868):572\u20137.","journal-title":"Nature"},{"issue":"24","key":"4192_CR15","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1056\/NEJMoa2307079","volume":"389","author":"E Wilson","year":"2023","unstructured":"Wilson E, Goswami J, Baqui AH, Doreski PA, Perez-Marc G, Zaman K, et al. Efficacy and safety of an mRNA-based RSV PreF vaccine in older adults. N Engl J Med. 2023;389(24):2233\u201344.","journal-title":"N Engl J Med"},{"issue":"D1","key":"4192_CR16","doi-asserted-by":"publisher","first-page":"D29","DOI":"10.1093\/nar\/gkac1032","volume":"51","author":"EW Sayers","year":"2023","unstructured":"Sayers EW, Bolton EE, Brister JR, Canese K, Chan J, Comeau DC, et al. Database resources of the National Center for Biotechnology Information in 2023. Nucleic Acids Res. 2023;51(D1):D29\u201338.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"4192_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s00894-014-2278-5","volume":"20","author":"I Dimitrov","year":"2014","unstructured":"Dimitrov I, Bangov I, Flower DR, Doytchinova I. AllerTOP v.2--a server for in silico prediction of allergens. J Mol Model. 2014;20(6):2278.","journal-title":"J Mol Model"},{"key":"4192_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbac174","author":"N Sharma","year":"2022","unstructured":"Sharma N, Naorem LD, Jain S, Raghava GPS. ToxinPred2: an improved method for predicting toxicity of proteins. Brief Bioinform. 2022. https:\/\/doi.org\/10.1093\/bib\/bbac174.","journal-title":"Brief Bioinform"},{"key":"4192_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-8-4","volume":"8","author":"IA Doytchinova","year":"2007","unstructured":"Doytchinova IA, Flower DR. VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinformatics. 2007;8:4.","journal-title":"BMC Bioinformatics"},{"key":"4192_CR20","volume-title":"The proteomics protocols handbook","author":"E Gasteiger","year":"2005","unstructured":"Gasteiger E. Protein identification and analysis tools on the ExPASy server. In: The proteomics protocols handbook. Human Press Inc.; 2005."},{"issue":"7","key":"4192_CR21","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/s41587-021-01156-3","volume":"40","author":"F Teufel","year":"2022","unstructured":"Teufel F, Almagro Armenteros JJ, Johansen AR, G\u00edslason MH, Pihl SI, Tsirigos KD, et al. SignalP 6.0 predicts all five types of signal peptides using protein language models. Nat Biotechnol. 2022;40(7):1023\u20135.","journal-title":"Nat Biotechnol"},{"issue":"W1","key":"4192_CR22","doi-asserted-by":"publisher","first-page":"W449","DOI":"10.1093\/nar\/gkaa379","volume":"48","author":"B Reynisson","year":"2020","unstructured":"Reynisson B, Alvarez B, Paul S, Peters B, Nielsen M. NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data. Nucleic Acids Res. 2020;48(W1):W449\u201354.","journal-title":"Nucleic Acids Res"},{"key":"4192_CR23","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/978-1-0716-3874-3_14","volume":"2809","author":"J Racle","year":"2024","unstructured":"Racle J, Gfeller D. How to predict binding specificity and ligands for new MHC-II alleles with MixMHC2pred. Methods Mol Biol. 2024;2809:215\u201335.","journal-title":"Methods Mol Biol"},{"key":"4192_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/cpim.12","author":"S Paul","year":"2016","unstructured":"Paul S, Sidney J, Sette A, Peters B. TepiTool: a pipeline for computational prediction of T cell epitope candidates. Curr Protoc Immunol. 2016. https:\/\/doi.org\/10.1002\/cpim.12.","journal-title":"Curr Protoc Immunol"},{"issue":"1","key":"4192_CR25","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/prot.21078","volume":"65","author":"S Saha","year":"2006","unstructured":"Saha S, Raghava GPS. Prediction of continuous B-cell epitopes in an antigen using recurrent neural network. Proteins. 2006;65(1):40\u20138.","journal-title":"Proteins"},{"key":"4192_CR26","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/978-1-0716-0389-5_17","volume":"2131","author":"B Yao","year":"2020","unstructured":"Yao B, Zheng D, Liang S, Zhang C. SVMTriP: a method to predict B-cell linear antigenic epitopes. Methods Mol Biol. 2020;2131:299\u2013307.","journal-title":"Methods Mol Biol"},{"key":"4192_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2024.108926","volume":"179","author":"AS Rathore","year":"2024","unstructured":"Rathore AS, Choudhury S, Arora A, Tijare P, Raghava GPS. ToxinPred 3.0: an improved method for predicting the toxicity of peptides. Comput Biol Med. 2024;179:108926.","journal-title":"Comput Biol Med"},{"key":"4192_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6150-8-30","volume":"8","author":"SK Dhanda","year":"2013","unstructured":"Dhanda SK, Vir P, Raghava GPS. Designing of interferon-gamma inducing MHC class-II binders. Biol Direct. 2013;8:30.","journal-title":"Biol Direct"},{"key":"4192_CR29","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/263952","author":"SK Dhanda","year":"2013","unstructured":"Dhanda SK, Gupta S, Vir P, Raghava GPS. Prediction of IL4 inducing peptides. Clin Dev Immunol. 2013. https:\/\/doi.org\/10.1155\/2013\/263952.","journal-title":"Clin Dev Immunol"},{"issue":"8","key":"4192_CR30","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.molp.2020.06.009","volume":"13","author":"C Chen","year":"2020","unstructured":"Chen C, Chen H, Zhang Y, Thomas HR, Frank MH, He Y, et al. TBtools: an integrative toolkit developed for interactive analyses of big biological data. Mol Plant. 2020;13(8):1194\u2013202.","journal-title":"Mol Plant"},{"key":"4192_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7007-4-41","volume":"4","author":"EM Gertz","year":"2006","unstructured":"Gertz EM, Yu YK, Agarwala R, Sch\u00e4ffer AA, Altschul SF. Composition-based statistics and translated nucleotide searches: improving the TBLASTN module of BLAST. BMC Biol. 2006;4:41.","journal-title":"BMC Biol"},{"issue":"Database issue","key":"4192_CR32","doi-asserted-by":"publisher","first-page":"D571","DOI":"10.1093\/nar\/gku1207","volume":"43","author":"JR Brister","year":"2015","unstructured":"Brister JR, Ako-Adjei D, Bao Y, Blinkova O. NCBI viral genomes resource. Nucleic Acids Res. 2015;43(Database issue):D571-577.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"4192_CR33","doi-asserted-by":"publisher","first-page":"W419","DOI":"10.1093\/nar\/gkv456","volume":"43","author":"M Kurcinski","year":"2015","unstructured":"Kurcinski M, Jamroz M, Blaszczyk M, Kolinski A, Kmiecik S. CABS-dock web server for the flexible docking of peptides to proteins without prior knowledge of the binding site. Nucleic Acids Res. 2015;43(W1):W419-424.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"4192_CR34","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, et al. The Protein Data Bank. Nucleic Acids Res. 2000;28(1):235\u201342.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"4192_CR35","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G, Gumienny R, et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 2018;46(W1):W296\u2013303.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"4192_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/wcms.1298","volume":"7","author":"S Yuan","year":"2017","unstructured":"Yuan S, Chan HCS, Hu Z. Using PyMOL as a platform for computational drug design. WIREs Comput Mol Sci. 2017;7(2): e1298. https:\/\/doi.org\/10.1002\/wcms.1298.","journal-title":"WIREs Comput Mol Sci"},{"key":"4192_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-7-153","volume":"7","author":"H-H Bui","year":"2006","unstructured":"Bui H-H, Sidney J, Dinh K, Southwood S, Newman MJ, Sette A. Predicting population coverage of T-cell epitope-based diagnostics and vaccines. BMC Bioinformatics. 2006;7:153.","journal-title":"BMC Bioinformatics"},{"issue":"2","key":"4192_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030839","volume":"7","author":"A Shanmugam","year":"2012","unstructured":"Shanmugam A, Rajoria S, George AL, Mittelman A, Suriano R, Tiwari RK. Synthetic Toll like receptor-4 (TLR-4) agonist peptides as a novel class of adjuvants. PLoS ONE. 2012;7(2):e30839.","journal-title":"PLoS ONE"},{"issue":"8","key":"4192_CR39","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1158\/0008-5472.CAN-10-3487","volume":"71","author":"ID Jung","year":"2011","unstructured":"Jung ID, Jeong SK, Lee CM, Noh KT, Heo DR, Shin YK, et al. Enhanced efficacy of therapeutic cancer vaccines produced by co-treatment with Mycobacterium tuberculosis heparin-binding hemagglutinin, a novel TLR4 agonist. Cancer Res. 2011;71(8):2858\u201370.","journal-title":"Cancer Res"},{"issue":"2","key":"4192_CR40","doi-asserted-by":"publisher","first-page":"123","DOI":"10.4110\/in.2011.11.2.123","volume":"11","author":"KH Kim","year":"2011","unstructured":"Kim KH, Yang CS, Shin AR, Jeon SR, Park JK, Kim HJ, et al. Mycobacterial heparin-binding hemagglutinin antigen activates inflammatory responses through PI3-K\/Akt, NF-\u03baB, and MAPK pathways. Immune Netw. 2011;11(2):123\u201333.","journal-title":"Immune Netw"},{"issue":"8","key":"4192_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0104351","volume":"9","author":"SJ Lee","year":"2014","unstructured":"Lee SJ, Shin SJ, Lee MH, Lee MG, Kang TH, Park WS, et al. A potential protein adjuvant derived from Mycobacterium tuberculosis Rv0652 enhances dendritic cells-based tumor immunotherapy. PLoS ONE. 2014;9(8):e104351.","journal-title":"PLoS ONE"},{"issue":"2","key":"4192_CR42","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.4049\/jimmunol.172.2.1146","volume":"172","author":"DJ Davidson","year":"2004","unstructured":"Davidson DJ, Currie AJ, Reid GS, Bowdish DM, MacDonald KL, Ma RC, et al. The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J Immunol. 2004;172(2):1146\u201356.","journal-title":"J Immunol"},{"issue":"5","key":"4192_CR43","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1002\/eji.201444988","volume":"45","author":"SH Kim","year":"2015","unstructured":"Kim SH, Yang IY, Kim J, Lee KY, Jang YS. Antimicrobial peptide LL-37 promotes antigen-specific immune responses in mice by enhancing Th17-skewed mucosal and systemic immunities. Eur J Immunol. 2015;45(5):1402\u201313.","journal-title":"Eur J Immunol"},{"issue":"5","key":"4192_CR44","doi-asserted-by":"publisher","DOI":"10.4110\/in.2022.22.e41","volume":"22","author":"J Kim","year":"2022","unstructured":"Kim J, Yang YL, Jeong Y, Jang YS. Application of antimicrobial peptide LL-37 as an adjuvant for Middle East respiratory syndrome-coronavirus antigen induces an efficient protective immune response against viral infection after intranasal immunization. Immune Netw. 2022;22(5):e41.","journal-title":"Immune Netw"},{"issue":"1","key":"4192_CR45","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1600-065X.2009.00782.x","volume":"229","author":"R Elgueta","year":"2009","unstructured":"Elgueta R, Benson MJ, de Vries VC, Wasiuk A, Guo Y, Noelle RJ. Molecular mechanism and function of CD40\/CD40L engagement in the immune system. Immunol Rev. 2009;229(1):152\u201372.","journal-title":"Immunol Rev"},{"issue":"4","key":"4192_CR46","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1128\/JVI.80.4.1762-1772.2006","volume":"80","author":"GW Stone","year":"2006","unstructured":"Stone GW, Barzee S, Snarsky V, Kee K, Spina CA, Yu XF, et al. Multimeric soluble CD40 ligand and GITR ligand as adjuvants for human immunodeficiency virus DNA vaccines. J Virol. 2006;80(4):1762\u201372.","journal-title":"J Virol"},{"issue":"17","key":"4192_CR47","doi-asserted-by":"publisher","first-page":"9579","DOI":"10.1128\/JVI.00975-14","volume":"88","author":"S Kwa","year":"2014","unstructured":"Kwa S, Lai L, Gangadhara S, Siddiqui M, Pillai VB, Labranche C, et al. CD40L-adjuvanted DNA\/modified vaccinia virus Ankara simian immunodeficiency virus SIV239 vaccine enhances SIV-specific humoral and cellular immunity and improves protection against a heterologous SIVE660 mucosal challenge. J Virol. 2014;88(17):9579\u201389.","journal-title":"J Virol"},{"key":"4192_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.785349","volume":"12","author":"LA Tamming","year":"2021","unstructured":"Tamming LA, Duque D, Tran A, Zhang W, Pfeifle A, Laryea E, et al. DNA based vaccine expressing SARS-CoV-2 spike-CD40L fusion protein confers protection against challenge in a Syrian hamster model. Front Immunol. 2021;12:785349.","journal-title":"Front Immunol"},{"issue":"9","key":"4192_CR49","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1093\/infdis\/jir548","volume":"204","author":"U Gowthaman","year":"2011","unstructured":"Gowthaman U, Singh V, Zeng W, Jain S, Siddiqui KF, Chodisetti SB, et al. Promiscuous peptide of 16 kDa antigen linked to Pam2Cys protects against Mycobacterium tuberculosis by evoking enduring memory T-cell response. J Infect Dis. 2011;204(9):1328\u201338.","journal-title":"J Infect Dis"},{"issue":"43","key":"4192_CR50","doi-asserted-by":"publisher","first-page":"15440","DOI":"10.1073\/pnas.0406740101","volume":"101","author":"DC Jackson","year":"2004","unstructured":"Jackson DC, Lau YF, Le T, Suhrbier A, Deliyannis G, Cheers C, et al. A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses. Proc Natl Acad Sci U S A. 2004;101(43):15440\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4192_CR51","doi-asserted-by":"publisher","first-page":"6972","DOI":"10.1038\/s41467-022-34297-3","volume":"13","author":"AS Ashhurst","year":"2022","unstructured":"Ashhurst AS, Johansen MD, Maxwell JWC, Stockdale S, Ashley CL, Aggarwal A, et al. Mucosal TLR2-activating protein-based vaccination induces potent pulmonary immunity and protection against SARS-CoV-2 in mice. Nat Commun. 2022;13(1):6972.","journal-title":"Nat Commun"},{"key":"4192_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.947852","volume":"13","author":"P Cheng","year":"2022","unstructured":"Cheng P, Wang L, Gong W. In silico analysis of peptide-based biomarkers for the diagnosis and prevention of latent tuberculosis infection. Front Microbiol. 2022;13:947852.","journal-title":"Front Microbiol"},{"key":"4192_CR53","doi-asserted-by":"publisher","DOI":"10.1007\/s12602-026-11005-x","author":"C Tan","year":"2026","unstructured":"Tan C, Wu A, Li C. Subtractive proteomics and immunoinformatics-guided design of a multi-epitope vaccine against Aspergillus fumigatus. Probiotics Antimicrob Proteins. 2026. https:\/\/doi.org\/10.1007\/s12602-026-11005-x.","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"6","key":"4192_CR54","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/sj.mt.6300121","volume":"15","author":"C-F Hung","year":"2007","unstructured":"Hung C-F, Tsai Y-C, He L, Wu TC. DNA vaccines encoding Ii-PADRE generates potent PADRE-specific CD4+ T-cell immune responses and enhances vaccine potency. Mol Ther. 2007;15(6):1211\u20139.","journal-title":"Mol Ther"},{"issue":"1","key":"4192_CR55","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00253-015-6985-3","volume":"100","author":"G Li","year":"2016","unstructured":"Li G, Huang Z, Zhang C, Dong BJ, Guo RH, Yue HW, et al. Construction of a linker library with widely controllable flexibility for fusion protein design. Appl Microbiol Biotechnol. 2016;100(1):215\u201325.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"17","key":"4192_CR56","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1093\/bioinformatics\/btp386","volume":"25","author":"CN Magnan","year":"2009","unstructured":"Magnan CN, Randall A, Baldi P. SOLpro: accurate sequence-based prediction of protein solubility. Bioinformatics. 2009;25(17):2200\u20137.","journal-title":"Bioinformatics"},{"issue":"19","key":"4192_CR57","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1093\/bioinformatics\/btx345","volume":"33","author":"M Hebditch","year":"2017","unstructured":"Hebditch M, Carballo-Amador MA, Charonis S, Curtis R, Warwicker J. Protein-Sol: a web tool for predicting protein solubility from sequence. Bioinformatics. 2017;33(19):3098\u2013100.","journal-title":"Bioinformatics"},{"key":"4192_CR58","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/S0076-6879(96)66034-0","volume":"266","author":"J Garnier","year":"1996","unstructured":"Garnier J, Gibrat JF, Robson B. GOR method for predicting protein secondary structure from amino acid sequence. Methods Enzymol. 1996;266:540\u201353.","journal-title":"Methods Enzymol"},{"issue":"W1","key":"4192_CR59","doi-asserted-by":"publisher","first-page":"W174","DOI":"10.1093\/nar\/gkv342","volume":"43","author":"J Yang","year":"2015","unstructured":"Yang J, Zhang Y. I-TASSER server: new development for protein structure and function predictions. Nucleic Acids Res. 2015;43(W1):W174-181.","journal-title":"Nucleic Acids Res"},{"issue":"Web Server issu","key":"4192_CR60","doi-asserted-by":"publisher","first-page":"W526","DOI":"10.1093\/nar\/gkh468","volume":"32","author":"DE Kim","year":"2004","unstructured":"Kim DE, Chivian D, Baker D. Protein structure prediction and analysis using the Robetta server. Nucleic Acids Res. 2004;32(Web Server issue):W526\u201331.","journal-title":"Nucleic Acids Res"},{"key":"4192_CR61","unstructured":"Team BAAS, Chen X, Zhang Y, Lu C, Ma W, Guan J, Gong C, Yang J, Zhang H, Zhang K, Wu S, Zhou K, Yang Y, Liu Z, Wang L, Shi B, Shi S, Xiao W. Protenix - Advancing Structure Prediction Through a Comprehensive AlphaFold3 Reproduction. bioRxiv. 2025;2025.2001.2008.631967."},{"issue":"8016","key":"4192_CR62","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson J, Adler J, Dunger J, Evans R, Green T, Pritzel A, et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature. 2024;630(8016):493\u2013500.","journal-title":"Nature"},{"issue":"Web Server issu","key":"4192_CR63","doi-asserted-by":"publisher","first-page":"W407","DOI":"10.1093\/nar\/gkm290","volume":"35","author":"M Wiederstein","year":"2007","unstructured":"Wiederstein M, Sippl MJ. ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res. 2007;35(Web Server issue):W407\u201310.","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"4192_CR64","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1002\/pro.5560020916","volume":"2","author":"C Colovos","year":"1993","unstructured":"Colovos C, Yeates TO. Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci. 1993;2(9):1511\u20139.","journal-title":"Protein Sci"},{"issue":"10","key":"4192_CR65","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1086\/379196","volume":"188","author":"KU Saikh","year":"2003","unstructured":"Saikh KU, Lee JS, Kissner TL, Dyas B, Ulrich RG. Toll-like receptor and cytokine expression patterns of CD56+ T cells are similar to natural killer cells in response to infection with Venezuelan equine encephalitis virus replicons. J Infect Dis. 2003;188(10):1562\u201370.","journal-title":"J Infect Dis"},{"issue":"Pt 8","key":"4192_CR66","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1099\/vir.0.010280-0","volume":"90","author":"A Sharma","year":"2009","unstructured":"Sharma A, Maheshwari RK. Oligonucleotide array analysis of Toll-like receptors and associated signalling genes in Venezuelan equine encephalitis virus-infected mouse brain. J Gen Virol. 2009;90(Pt 8):1836\u201347.","journal-title":"J Gen Virol"},{"issue":"2","key":"4192_CR67","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nprot.2016.169","volume":"12","author":"D Kozakov","year":"2017","unstructured":"Kozakov D, Hall DR, Xia B, Porter KA, Padhorny D, Yueh C, et al. The ClusPro web server for protein-protein docking. Nat Protoc. 2017;12(2):255\u201378.","journal-title":"Nat Protoc"},{"key":"4192_CR68","doi-asserted-by":"crossref","unstructured":"Honorato RV, Trellet ME, Jim\u00e9nez-Garc\u00eda B, Schaarschmidt JJ, Giulini M, Reys V, Koukos PI, Rodrigues J, Karaca E, van Zundert GCP, Roel-Touris J, van Noort CW, Jandov\u00e1 Z, Melquiond ASJ, Bonvin A. The HADDOCK2.4 web server for integrative modeling of biomolecular complexes. Nat Protoc. 2024;19(11):3219\u20133241.","DOI":"10.1038\/s41596-024-01011-0"},{"issue":"2","key":"4192_CR69","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1","author":"MJ Abraham","year":"2015","unstructured":"Abraham MJ, Murtola T, Schulz R, P\u00e1ll S, Smith JC, Hess B, et al. GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 2015;1(2):19\u201325.","journal-title":"SoftwareX"},{"issue":"10","key":"4192_CR70","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","volume":"17","author":"MS Vald\u00e9s-Tresanco","year":"2021","unstructured":"Vald\u00e9s-Tresanco MS, Vald\u00e9s-Tresanco ME, Valiente PA, Moreno E. gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS. J Chem Theory Comput. 2021;17(10):6281\u201391.","journal-title":"J Chem Theory Comput"},{"issue":"Web Server issu","key":"4192_CR71","doi-asserted-by":"publisher","first-page":"W271","DOI":"10.1093\/nar\/gku339","volume":"42","author":"JR L\u00f3pez-Blanco","year":"2014","unstructured":"L\u00f3pez-Blanco JR, Aliaga JI, Quintana-Ort\u00ed ES, Chac\u00f3n P. iMODS: internal coordinates normal mode analysis server. Nucleic Acids Res. 2014;42(Web Server issue):W271-276.","journal-title":"Nucleic Acids Res"},{"issue":"14","key":"4192_CR72","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1093\/bioinformatics\/btr335","volume":"27","author":"N Rapin","year":"2011","unstructured":"Rapin N, Lund O, Castiglione F. Immune system simulation online. Bioinformatics. 2011;27(14):2013\u20134.","journal-title":"Bioinformatics"},{"issue":"Web Server issu","key":"4192_CR73","doi-asserted-by":"publisher","first-page":"W526","DOI":"10.1093\/nar\/gki376","volume":"33","author":"A Grote","year":"2005","unstructured":"Grote A, Hiller K, Scheer M, M\u00fcnch R, N\u00f6rtemann B, Hempel DC, et al. JCat: a novel tool to adapt codon usage of a target gene to its potential expression host. Nucleic Acids Res. 2005;33(Web Server issue):W526\u201331.","journal-title":"Nucleic Acids Res"},{"issue":"Web Server issu","key":"4192_CR74","doi-asserted-by":"publisher","first-page":"W70","DOI":"10.1093\/nar\/gkn188","volume":"36","author":"AR Gruber","year":"2008","unstructured":"Gruber AR, Lorenz R, Bernhart SH, Neub\u00f6ck R, Hofacker IL. The Vienna RNA websuite. Nucleic Acids Res. 2008;36(Web Server issue):W70\u20134.","journal-title":"Nucleic Acids Res"},{"key":"4192_CR75","doi-asserted-by":"crossref","unstructured":"Pedersen CE Jr. Preparation and testing of vaccines prepared from the envelopes of Venezuelan, eastern, and western equine encephalomyelitis viruses. J Clin Microbiol. 1976;3(2):113\u20138.","DOI":"10.1128\/jcm.3.2.113-118.1976"},{"issue":"34","key":"4192_CR76","doi-asserted-by":"publisher","first-page":"5194","DOI":"10.1016\/j.vaccine.2018.06.064","volume":"36","author":"WG Hu","year":"2018","unstructured":"Hu WG, Steigerwald R, Kalla M, Volkmann A, Noll D, Nagata LP. Protective efficacy of monovalent and trivalent recombinant MVA-based vaccines against three encephalitic alphaviruses. Vaccine. 2018;36(34):5194\u2013203.","journal-title":"Vaccine"},{"key":"4192_CR77","doi-asserted-by":"publisher","DOI":"10.3390\/v14071502","author":"CW Burke","year":"2022","unstructured":"Burke CW, Erwin-Cohen RA, Goodson AI, Wilhelmsen C, Edmundson JA, White CE, et al. Efficacy of Western, Eastern, and Venezuelan Equine Encephalitis (WEVEE) virus-replicon particle (VRP) vaccine against WEEV in a non-human primate animal model. Viruses. 2022. https:\/\/doi.org\/10.3390\/v14071502.","journal-title":"Viruses"},{"key":"4192_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.598847","volume":"11","author":"L Henning","year":"2020","unstructured":"Henning L, Endt K, Steigerwald R, Anderson M, Volkmann A. A monovalent and trivalent MVA-based vaccine completely protects mice against lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus aerosol challenge. Front Immunol. 2020;11:598847.","journal-title":"Front Immunol"},{"key":"4192_CR79","doi-asserted-by":"crossref","unstructured":"Lam LKM, Gilliland T Jr., Dunn M, Alcorn-Burckhardt MD, Terada Y, Sun C, et al. An inactivated trivalent virion-based vaccine protects against aerosol challenge with encephalitic alphaviruses in mice and macaques. Sci Transl Med. 2025;17(818):eadv7079.","DOI":"10.1126\/scitranslmed.adv7079"},{"issue":"12","key":"4192_CR80","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1016\/j.immuni.2021.11.001","volume":"54","author":"MG Alameh","year":"2021","unstructured":"Alameh MG, Tomb\u00e1cz I, Bettini E, Lederer K, Sittplangkoon C, Wilmore JR, et al. Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses. Immunity. 2021;54(12):2877-2892.e2877.","journal-title":"Immunity"},{"key":"4192_CR81","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.antiviral.2019.02.002","volume":"164","author":"A Ahmed","year":"2019","unstructured":"Ahmed A, Siman-Tov G, Keck F, Kortchak S, Bakovic A, Risner K, et al. Human cathelicidin peptide LL-37 as a therapeutic antiviral targeting Venezuelan equine encephalitis virus infections. Antivir Res. 2019;164:61\u20139.","journal-title":"Antivir Res"},{"key":"4192_CR82","doi-asserted-by":"crossref","unstructured":"Pulendran B, P SA, O'Hagan DT. Emerging concepts in the science of vaccine adjuvants. Nat Rev Drug Discov. 2021;20(6):454\u2013475.","DOI":"10.1038\/s41573-021-00163-y"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04192-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-026-04192-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04192-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:02:37Z","timestamp":1790287357000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-026-04192-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":82,"alternative-id":["4192"],"URL":"https:\/\/doi.org\/10.1007\/s11095-026-04192-3","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"assertion":[{"value":"28 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}